Literature DB >> 25283642

Prevalence and prognostic value of human papillomavirus genotypes in tonsillar squamous cell carcinoma: a Korean multicenter study.

Jae Hong No1, Myung-Whun Sung, J Hun Hah, Seung Ho Choi, Myung-Chul Lee, Hee Seung Kim, Yong-Sang Song.   

Abstract

BACKGROUND: This study was aimed at investigating the change in the prevalence of human papillomavirus (HPV) genotypes in tonsillar squamous cell carcinoma (TSCC) and the association of the HPV genotype with the prognosis.
METHODS: This multicenter study included 175 patients with TSCC from 3 general hospitals between 1991 and 2009. HPV DNA was detected in paraffin-embedded tissues with genotyping chips. A survival analysis that considered clinicopathological factors, the HPV genotype, and the expression of p53, retinoblastoma protein, p16, and epidermal growth factor receptor (assessed with immunohistochemistry) was performed with Cox regression analysis.
RESULTS: High-risk HPV types were found in 23.4% of the cases. The prevalence of HPV-18 (10.3%) was as high as that of HPV-16 (10.3%). The proportion of high-risk HPV-positive tumors increased from 5.9% in 1991 to 31.6% in 2009. HPV-16 positivity was associated with an advanced stage and lymph node metastasis, whereas HPV-18 positivity was associated with old age and an advanced T stage. The survival analysis showed that old age and T classification were poor prognostic factors, whereas the expressions of various biomarkers were not associated with prognosis. HPV-18-positive cases had a poorer prognosis than HPV-16-positive cases and non-HPV-related TSCC cases. A multivariate analysis revealed that HPV-18 positivity, old age, and an advanced T stage were independent prognostic factors for predicting poor outcomes for patients with TSCC.
CONCLUSIONS: The proportion of HPV-positive tonsillar cancer cases has increased during the last 20 years in the Republic of Korea. The presence of HPV-18 may serve as a biomarker for a poor prognosis.
© 2014 American Cancer Society.

Entities:  

Keywords:  biomarker; genotype; human papillomavirus; prognosis; tonsillar cancer

Mesh:

Substances:

Year:  2014        PMID: 25283642     DOI: 10.1002/cncr.29086

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  Prognostic significance of non-HPV16 genotypes in oropharyngeal squamous cell carcinoma.

Authors:  Angela L Mazul; Nidia Rodriguez-Ormaza; James M Taylor; Dipan D Desai; Paul Brennan; Devasena Anantharaman; Tarik Gheit; Massimo Tommasino; Behnoush Abedi-Ardekani; Andrew F Olshan; Jose P Zevallos
Journal:  Oral Oncol       Date:  2016-09-06       Impact factor: 5.337

2.  HPV33+ HNSCC is associated with poor prognosis and has unique genomic and immunologic landscapes.

Authors:  Kate Chatfield-Reed; Shanying Gui; Wendi Q O'Neill; Theodoros N Teknos; Quintin Pan
Journal:  Oral Oncol       Date:  2019-12-10       Impact factor: 5.337

3.  Prognostic factors for human papillomavirus-positive and negative oropharyngeal carcinomas.

Authors:  Linda X Yin; Gypsyamber D'Souza; William H Westra; Steven J Wang; Annemieke van Zante; Yuehan Zhang; Eleni M Rettig; William R Ryan; Patrick K Ha; Alicia Wentz; Wayne Koch; David W Eisele; Carole Fakhry
Journal:  Laryngoscope       Date:  2018-03-14       Impact factor: 3.325

4.  Burden of Human papillomavirus (HPV)-related disease and potential impact of HPV vaccines in the Republic of Korea.

Authors:  Young-Tak Kim; Beatriz Serrano; Jae-Kwan Lee; Hyunju Lee; Shin-Wha Lee; Crystal Freeman; Jin-Kyoung Oh; Laia Alemany; Francesc-Xavier Bosch; Laia Bruni
Journal:  Papillomavirus Res       Date:  2018-12-30

5.  Poor prognostic factors in human papillomavirus-positive head and neck cancer: who might not be candidates for de-escalation treatment?

Authors:  Shin Hye Yoo; Chan-Young Ock; Bhumsuk Keam; Sung Joon Park; Tae Min Kim; Jin Ho Kim; Yoon Kyung Jeon; Eun-Jae Chung; Seong Keun Kwon; J Hun Hah; Tack-Kyun Kwon; Kyeong Chun Jung; Dong-Wan Kim; Hong-Gyun Wu; Myung-Whun Sung; Dae Seog Heo
Journal:  Korean J Intern Med       Date:  2018-11-16       Impact factor: 2.884

6.  Does HPV Subtype Predict Outcomes in Head and Neck Cancers?

Authors:  Hedyeh Ziai; Andrew Warner; Neil Mundi; Krupal Patel; Eun Jae Chung; Christopher J Howlett; Paul Plantinga; John Yoo; S Danielle MacNeil; Kevin Fung; Joe S Mymryk; John W Barrett; David A Palma; Anthony C Nichols
Journal:  Int J Otolaryngol       Date:  2021-02-09

7.  Positive Rate of Human Papillomavirus and Its Trend in Head and Neck Cancer in South Korea.

Authors:  Hyun Woong Jun; Yong Bae Ji; Chang Myeon Song; Jae Kyung Myung; Hae Jin Park; Kyung Tae
Journal:  Front Surg       Date:  2022-01-21

8.  Association of Human Papillomavirus and Epstein-Barr Virus Infection with Tonsil Cancer in Northeastern Thailand.

Authors:  Chukkris Heawchaiyaphum; Tipaya Ekalaksananan; Natcha Patarapadungkit; Patravoot Vatanasapt; Chamsai Pientong
Journal:  Asian Pac J Cancer Prev       Date:  2022-03-01

Review 9.  The Role of Human Papilloma Virus in Dictating Outcomes in Head and Neck Squamous Cell Carcinoma.

Authors:  Shane Brennan; Anne-Marie Baird; Esther O'Regan; Orla Sheils
Journal:  Front Mol Biosci       Date:  2021-06-23

Review 10.  Human Papillomavirus and Squamous Cell Carcinoma of Unknown Primary in the Head and Neck Region: A Comprehensive Review on Clinical Implications.

Authors:  Mikkel Hjordt Holm Larsen; Hani Ibrahim Channir; Christian von Buchwald
Journal:  Viruses       Date:  2021-07-02       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.